David Brown, Director Of Chemistry at Seal Rock Therapeutics

David Brown

Director Of Chemistry at Seal Rock Therapeutics | San Carlos, California, United States

Profile last verified August 2026
Pharmaceuticals Verified Profile San Carlos, California, United States UCLA
Verified

Personal Email

***@stanfordalumni.org

Personal • High Confidence

Phone Number

(213) ***-*291

United States • Phone

Free account · No credit card · 5 profiles/month

David Brown Socials
David Brown Work Experience

Director Of Chemistry at Seal Rock Therapeutics in May 2016 - Present

Medicinal Chemistry Consultant at Zenith Epigenetics in June 2014 - April 2016

Medicinal Chemistry Consultant at Pathway Therapeutics, Inc. in November 2010 - June 2013

See more See less

Senior Scientist at Exelixis in July 1999 - May 2010

Research Scientist at MetaXen in August 1997 - July 1999

David Brown Education

UCLA, January 1992 to January 1997

Stanford University, January 1988 to January 1992

David Brown Skills
Medicinal Chemistry Oncology Drug Development Drug Discovery Chemistry Combinatorial Chemistry Drug Design Kinases Biomarker Discovery Inflammation Biotechnology Organic Chemistry Technology Transfer LC-MS Organic Synthesis Life Sciences
About David Brown’s Current Company
David Brown’s Colleagues
Terry Porter

Terry Porter

Greater Chicago Area

SVP Business Development at Seal Rock Therapeutics

SVP Business Development at Seal Rock Therapeutics
(February 2017 – Present)

Jade Brown

Jade Brown

Greater Seattle Area

Biotechnology Transactional Advisor and Investor

Transactional Advisor at FRONTEO USA
(Apr 2026 – Present)

Artur Plonowski

Artur Plonowski

Cupertino, California, United States

Serial biotech entrepreneur, CEO of Vasa Therapeutics, Co-founder of Seal Rock Therapeutics, Vasa Therapeutics, and Orphinic Scientific

Co-Founder at Orphinic Scientific
(Jan 2020 – Present)

Neil Mcdonnell

Neil Mcdonnell

Seattle, Washington, United States

CEO at Seal Rock Therapeutics

Seal Rock Therapeutics, Inc. is a clinical stage company developing small molecule kinase inhibitors. Seal Rock’s most advanced program is a phase 2-ready, liver-directed ASK1 inhibitor being developed for acute and chronic liver disease. Seal Rock’s next program is a gr...

Eli Wang

Eli Wang

Seattle, Washington, United States

Biotech Finance Leader | Co-founder at Subject Design | Founder at Ninebark Group LLC

VP Finance & Operations at Vasa Therapeutics
(Aug 2025 – Present)

Kathleen Elias

Kathleen Elias

San Francisco, California, United States

Co-founder and Vice President at Seal Rock Therapeutics

Seal Rock Therapeutics, Inc. is a discovery stage company developing small molecule inhibitors to a protein that mediates apoptosis, inflammation, and fibrosis. Seal Rock is focusing its efforts on NASH (non-alcoholic steatohepatitis), a condition resulting from fatty liver d...

Search similar profiles
Frequently asked questions about David Brown

What is David Brown email address?

Email David Brown at [email protected] and [email protected]. This email is the most updated David Brown's email found in 2026.

How to contact David Brown?

To contact David Brown send an email to [email protected] or [email protected].

What company does David Brown work for?

David Brown works for Seal Rock Therapeutics.

What is David Brown's role at Seal Rock Therapeutics?

David Brown is Director Of Chemistry

What industry does David Brown work in?

David Brown works in the Pharmaceuticals industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free